Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin Type A in Patients With Restless Legs Syndrome
NCT00949806Phase 2Completed
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Aug 2009
- Primary completion
- May 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in restless legs syndrome (RLS), sponsored by Centre Hospitalier Universitaire de Bordeaux. Started Aug 2009; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT00949806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00949806.